Who is eligible for MIPS 048?

All female patients aged 65 years and older with a visit during the measurement period.

Is MIPS 48 the same as MIPS 048?

Yes. CMS uses zero-padded three-digit Quality IDs (048) in official specifications, while clinicians often search for MIPS 48 or Quality ID 48 without the leading zero. Both refer to the same 2026 MIPS quality measure reported through the Quality Payment Program (QPP).

How do I report MIPS Measure 048 in 2026?

MIPS Measure 048 (Quality ID 48) is reported through the Quality Payment Program (QPP) as a MIPS Clinical Quality Measure (CQM) via qualified registry, or Medicare Part B claims where applicable.

Is MIPS 048 a topped-out measure?

Yes, MIPS 048 is currently topped out, which means most clinicians perform well on this measure and it may be subject to a 7-point scoring cap.

Measure ID: MIPS 048|Functional Assessment|2026 Performance Year

2026 MIPS Measure #048: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in

Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 months.

ProcessFunctional AssessmentGeriatricsUrology

Measure ID:MIPS 048 (Quality ID 48)

Collection:MIPS CQM

Topped Out:Yes

View CMS Spec ↗

Measure Specification

Eligible Population

All female patients aged ≥ 65 years on date of encounter

ANDPatient encounter during the performance period

Exclusions

G9693Patient use of hospice services any time during the measurement period

Numerator

Patients who were assessed for the presence or absence of urinary incontinence within 12 months.

Reporting Codes

Performance Met:

1090FPresence or absence of urinary incontinence assessed

Performance Not Met:

1090F with 8PPresence or absence of urinary incontinence not assessed, reason not otherwise specified

VBCA Insights

Why This Measure Matters

This measure checks whether older women are routinely asked about urinary incontinence, since many won't volunteer this problem. Incontinence is treatable and profoundly affects quality of life; screening enables discussion of options ranging from pelvic floor exercises to medications. Add a simple screening question to your standard assessment for women 65 and older. A positive response opens the door to practical interventions that patients often greatly appreciate.

VBCA is a CMS-approved Qualified Clinical Data Registry (QCDR) that submits MIPS Measure 048 to the Quality Payment Program (QPP). Practices can report this measure as a MIPS Clinical Quality Measure (CQM) or through qualified registry submission.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

Your Performance Rate:%Benchmarks vary by collection type

💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.

Specialty Measure Sets

Family Medicine Geriatrics Internal Medicine Obstetrics/Gynecology Physical Therapy/Occupational Therapy Preventive Medicine Urology

Related Measures

Functional Assessment

MIPS 050: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years MIPS 126: Diabetes Mellitus: Diabetic Foot and Ankle Care Peripheral Neuropathy – Neurological Evaluation MIPS 127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of MIPS 178: Rheumatoid Arthritis (RA): Functional Status Assessment MIPS 182: Functional Outcome Assessment MIPS 282: Dementia: Functional Status Assessment MIPS 502: Improvement or Maintenance of Functioning for Individuals with a Mental and/or

Geriatrics

MIPS 050: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years MIPS 155: Falls: Plan of Care MIPS 181: Elder Maltreatment Screen and Follow-Up Plan MIPS 238: Use of High-Risk Medications in Older Adults MIPS 282: Dementia: Functional Status Assessment MIPS 286: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia MIPS 288: Dementia: Education and Support of Caregivers for Patients with Dementia MIPS 500: Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up MIPS 501: Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate MIPS 513: Patient Reported Falls and Plan of Care

Urology

MIPS 050: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years MIPS 102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate MIPS 250: Radical Prostatectomy Pathology Reporting MIPS 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse MIPS 432: Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any Pelvic

Official Resources

📄 CMS Measure Specification (PDF)🔗 QPP Quality Payment Program

Clinical Rationale

Female patients may not volunteer information regarding incontinence, so they should be asked by their physician.

Clinical Recommendations

Strategies to increase recognition and reporting of urinary incontinence (UI) are required and especially the perception that it is an inevitable consequence of aging for which little or nothing can be done. (ICI) Patients with urinary incontinence should undergo a basic evaluation that includes a history, physical examination, measurement of post-void residual volume, and urinalysis.

(ACOG) (Level C) Health care providers should be able to initiate evaluation and treatment of UI basing their judgment on the results of history, physical examination, post-voiding residual and urinalysis.

Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this patient-process measure is submitted a minimum of once per patient during the performance period. The most advantageous quality data code will be used if the measure is submitted more than once.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →Talk to Us